Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1997 1
2000 1
2003 1
2007 1
2013 2
2014 2
2015 4
2016 5
2017 2
2018 1
2019 1
2020 2
2021 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Decreased specific pneumococcal antibody level"
Page 1
Differences in Pneumococcal and Haemophilus influenzae Natural Antibody Development in Papua New Guinean Children in the First Year of Life.
Martinovich KM, Rahman T, de Gier C, Seppanen EJ, Orami T, Granland CM, Francis J, Yoannes M, Corscadden KJ, Ford R, Jacoby P, van den Biggelaar AHJ, Bakaletz LO, Cripps AW, Lehmann D, Richmond PC, Pomat WS, Kirkham LS, Thornton RB. Martinovich KM, et al. Front Immunol. 2021 Aug 10;12:725244. doi: 10.3389/fimmu.2021.725244. eCollection 2021. Front Immunol. 2021. PMID: 34447389 Free PMC article. Clinical Trial.
RESULTS: Serum -pneumococcal protein-specific IgG titres followed a "U" shaped pattern, with a decrease in presumably maternally-derived IgG titres between 1 and 4 months of age and returning to similar levels as those measured at 1 month of age by 24 …
RESULTS: Serum -pneumococcal protein-specific IgG titres followed a "U" shaped pattern, with a decrease in presumably m …
Antigen-specific IgA titres after 23-valent pneumococcal vaccine indicate transient antibody deficiency disease in children.
Janssen WJ, Nierkens S, Sanders EA, Boes M, van Montfrans JM. Janssen WJ, et al. Vaccine. 2015 Nov 17;33(46):6320-6. doi: 10.1016/j.vaccine.2015.09.041. Epub 2015 Sep 28. Vaccine. 2015. PMID: 26413880
Transient antibody deficiency patients produced consistently higher levels of PnPS-specific IgA responses than antibody deficiency patients. ...We conclude that measuring PnPS-specific IgA responses may predict the disease course in young …
Transient antibody deficiency patients produced consistently higher levels of PnPS-specific IgA responses than antib …
Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage.
Pennington SH, Pojar S, Mitsi E, Gritzfeld JF, Nikolaou E, Solórzano C, Owugha JT, Masood Q, Gordon MA, Wright AD, Collins AM, Miyaji EN, Gordon SB, Ferreira DM. Pennington SH, et al. Am J Respir Crit Care Med. 2016 Dec 15;194(12):1523-1531. doi: 10.1164/rccm.201512-2467OC. Am J Respir Crit Care Med. 2016. PMID: 27403678 Free PMC article.
There were no associations between protection from carriage and baseline levels of 6BPS IgG in serum or nasal wash, PspA-specific, or PspC-specific memory B cells or plasma cells. ...CONCLUSIONS: Our data indicate that naturally acquired PS-specific me …
There were no associations between protection from carriage and baseline levels of 6BPS IgG in serum or nasal wash, PspA-specific …
Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults.
Ravichandran S, Erra-Diaz F, Karakaslar OE, Marches R, Kenyon-Pesce L, Rossi R, Chaussabel D, Nehar-Belaid D, LaFon DC, Pascual V, Palucka K, Paust S, Nahm MH, Kuchel GA, Banchereau J, Ucar D. Ravichandran S, et al. Nat Immunol. 2024 Feb;25(2):316-329. doi: 10.1038/s41590-023-01717-5. Epub 2024 Jan 5. Nat Immunol. 2024. PMID: 38182669 Free PMC article.
The capsular polysaccharide vaccine PPSV23 and conjugated alternative PCV13 can prevent these infections; yet, underlying immunological responses and baseline predictors remain unknown. We vaccinated 39 older adults (>60 years) with PPSV23 or PCV13 and observed c …
The capsular polysaccharide vaccine PPSV23 and conjugated alternative PCV13 can prevent these infections; yet, underlying immunological resp …
Sustained functional serotype-specific antibody after primary and secondary vaccinations with a pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.
Ohshima N, Nagai H, Matsui H, Akashi S, Makino T, Akeda Y, Oishi K. Ohshima N, et al. Vaccine. 2014 Feb 26;32(10):1181-6. doi: 10.1016/j.vaccine.2013.09.060. Epub 2013 Oct 9. Vaccine. 2014. PMID: 24120483
The levels of serotype-specific IgG and the OIs significantly increased 1 month after primary and secondary vaccinations. ...The levels of serotype-specific IgG required for 50% killing significantly decreased 1 month after vaccination. ...
The levels of serotype-specific IgG and the OIs significantly increased 1 month after primary and secondary vaccinations. ...T …
Carrier-Induced Hyporesponsiveness to Pneumococcal Conjugate Vaccines: Unraveling the Influence of Serotypes, Timing, and Previous Vaccine Dose.
Dagan R, Jiang Q, Juergens C, Trammel J, Gruber WC, Scott DA. Dagan R, et al. Clin Infect Dis. 2021 Feb 1;72(3):448-454. doi: 10.1093/cid/ciaa083. Clin Infect Dis. 2021. PMID: 31995183 Free PMC article. Clinical Trial.
BACKGROUND: Pneumococcal conjugate vaccines (PCVs) elicit lower immune response against serotypes carried before or at the time of vaccination (hyporesponsiveness) in infants. ...New acquisition was defined based on nasopharyngeal swabs at ages 2, 4, 6, 7, and 12 mo …
BACKGROUND: Pneumococcal conjugate vaccines (PCVs) elicit lower immune response against serotypes carried before or at the tim …
Phenotypic analysis of T follicular helper and T follicular regulatory cells in primary selective IgM deficiency.
Kasahara TM, Bento CAM, Gupta S. Kasahara TM, et al. Hum Immunol. 2020 Oct-Nov;81(10-11):625-633. doi: 10.1016/j.humimm.2020.07.008. Epub 2020 Aug 7. Hum Immunol. 2020. PMID: 32773096
Selective IgM deficiency (SIgMD) is a rare immunodeficiency characterized by serum IgM below two standard of mean, and normal IgG and IgA levels. Both in human and mice with selective IgM deficiency, germinal centers cells are decreased. ...When data were analyzed a …
Selective IgM deficiency (SIgMD) is a rare immunodeficiency characterized by serum IgM below two standard of mean, and normal IgG and IgA …
Immunogenicity and safety after the third vaccination with the 23-valent pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.
Ohshima N, Akeda Y, Nagai H, Oishi K. Ohshima N, et al. Hum Vaccin Immunother. 2020 Sep 1;16(9):2285-2291. doi: 10.1080/21645515.2020.1718975. Epub 2020 Feb 12. Hum Vaccin Immunother. 2020. PMID: 32048894 Free PMC article.
The level of serotype-specific IgG required for killing 50% of bacteria decreased significantly 1 month after the second vaccination. This level was slightly elevated immediately before the third vaccination but decreased after the third vaccina …
The level of serotype-specific IgG required for killing 50% of bacteria decreased significantly 1 month after the secon …
Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis.
Bahuaud M, Beaudouin-Bazire C, Husson M, Molto A, Launay O, Batteux F, Dougados M. Bahuaud M, et al. Hum Vaccin Immunother. 2018 Jun 3;14(6):1464-1470. doi: 10.1080/21645515.2018.1438091. Epub 2018 Apr 9. Hum Vaccin Immunother. 2018. PMID: 29432051 Free PMC article.
OBJECTIVES: Patients with rheumatoid arthritis (RA) are at an increased risk of Pneumococcal infections. Immunogenicity and persistence of a prime-boost revaccination strategy using 13-valent/23-valent anti-pneumococcal vaccines was evaluated in patients with …
OBJECTIVES: Patients with rheumatoid arthritis (RA) are at an increased risk of Pneumococcal infections. Immunogenicity and persisten …
Pneumococcal vaccine in patients with idiopathic juvenile arthritis in treatment with tumor necrosis factor inhibitors.
Berho J, Monsalvez MP, Rojas J, Inostroza J, Quezada A. Berho J, et al. Allergol Immunopathol (Madr). 2021 Jul 1;49(4):149-154. doi: 10.15586/aei.v49i4.203. eCollection 2021. Allergol Immunopathol (Madr). 2021. PMID: 34224229
Data obtained from the clinical records of an immunorheumatology polyclinic of a metropolitan hospital in Santiago (Chile). Treatments, pneumococcal vaccine schedules, immunological laboratory, and measurement of specific antibodies against 10 pneumococcal …
Data obtained from the clinical records of an immunorheumatology polyclinic of a metropolitan hospital in Santiago (Chile). Treatments, p …
25 results